Comparison

C4A Recombinant Protein

Item no. OPCD01763
Manufacturer AVIVA Systems Biology
Amount 10 ug
Category
Type Proteins Recombinant
Applications WB, SDS-PAGE
Specific against Human (Homo sapiens)
Host E.coli
Conjugate/Tag Unconjugated; HIS
Purity > 95%
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias acidic C4;acidic complement C4;basic complement C4;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3;C4;C4A anaphylatoxin;C4A2;C4A3;C4A4;C4A6;C4AD;C4B_2;C4B1;C4B12;C4B2;C4B3;C4B5;C4BD;C4F;C4S;CH;Chido form of C4;CO4;complement C4-A;complement C4-B;complement C4B1a;complement component 4A (Rodgers blood group);complement component 4B (Chido blood group);CPAMD2;CPAMD3;MHC class III region complement;RG;Rodgers form of C4.
Available
Manufacturer - Type
Protein
Manufacturer - Applications
Positive control|Sodium sodecyl sulfate - polyacrylamide gel electrophoresis|Western blot
Manufacturer - Category
Root Catalog/Products/Recombinant Proteins
Manufacturer - Conjugate / Tag
N-terminal His Tag
Molecular Weight
42kDa
Gene symbol
C4A|C4B
Gene Fullname
complement C4A (Rodgers blood group)|complement C4B (Chido blood group)
Protein size
Recombinant
Product format
Freeze-dried Powder. PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Reconstitution and storage
2°C to 8°C|-80°C
Description of target
Non-enzymatic component of C3 and C5 convertases and thus essential for the propagation of the classical complement pathway. Covalently binds to immunoglobulins and immune complexes and enhances the solubilization of immune aggregates and the clearance of IC through CR1 on erythrocytes. C4A isotype is responsible for effective binding to form amide bonds with immune aggregates or protein antigens, while C4B isotype catalyzes the transacylation of the thioester carbonyl group to form ester bonds with carbohydrate antigens.
Nucleotide accession_num
NM_001002029.3
Protein accession_num
NP_001002029.3
Protein name
Complement C4-A
Formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Concentration
200 ug/mL (prior to lyoph)

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 ug
Available: In stock
available

Delivery expected until 10/30/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close